More than 100 industry players and over 60 non-industry players currently claim to manufacture diffe

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry

 

To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

 

The USD 11 billion (by 2030) financial opportunity within the cell therapy manufacturing market has been analyzed across the following segments:

Type of therapy

T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)

Dendritic cell therapies

Tumor cell therapies

NK cell therapies

Stem cell therapies

Source of cellsAutologousAllogeneic

Scale of operation

ClinicalCommercial

Purpose of manufacturing

Contract manufacturingIn-house manufacturing

Key geographical regions

North America

Europe

Asia Pacific

Rest of the world

 

The Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030 report features the following companies, which we identified to be key players in this domain: 

BioNTech Innovative Manufacturing ServicesCell TherapiesCell and Gene Therapy CatapultCenter for Cell and Gene Therapy, Baylor College of MedicineCentre for Cell Manufacturing Ireland, National University of IrelandClinical Cell and Vaccine Production Facility, University of PennsylvaniaCognate BioServicesFUJIFILMGuy’s and St. Thomas’ GMP Facility, Guy’s HospitalHitachi ChemicalKBI BiopharmaLaboratory for Cell and Gene Medicine, Stanford UniversityLonzaMaSTherCellMEDINETMolecular and Cellular Therapeutics, University of MinnesotaNewcastle Cellular Therapies Facility, Newcastle UniversityNikon CeLL innovationRayne Cell Therapy Suite, King’s College LondonRoslin Cell TherapiesScottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative MedicineSydney Cell and Gene TherapyWuXi Advanced Therapies

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction

4. Market Overview

5. Regulatory Landscape 

6. Roadmaps for Overcoming Existing Challenges

 

7. Automation Technologies for Cell Therapy Manufacturing

8. Profiles: Industry Players

9. Profiles: Non-Industry Players

10. Role of Non-Profit Organizations

11. Partnerships

12. Facility Expansions

13. Capacity Analysis

14. Demand Analysis

15. Cost Price Analysis

16. Make Versus Buy Decision Making Framework

17. Market Sizing and Opportunity Analysis

 

18. Key Insights

19. SWOT Analysis

 

20. Conclusion

 

21. Survey Analysis

 

22. Interview Transcripts

 

23. Appendix 1: Tabulated Data

 

24. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit-  https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]